Psychedelic Therapy: Diplomatic Re-compositions of Life/Non-life, the Living and the Dead
Harish Naraindas
The Movement for Global Mental Health April 23, 2021 DOI: 10.1017/9789048550135.006 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Ethnography Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Citations | 1 |
| Key findings | Psychosomatic medicine in Germany eschews psycho-pharmaceuticals, contrasting with the pharmaceutical-centered mental health approach in the Global South, and the distinction between superstition and science is blurred in Germany but sharp in the Global South. |
Abstract
This chapter, which is an ethnography of a psychosomatic department in a German hospital, functions as a foil to the rest of the volume. It allows us to ask the following: Why is the movement for global mental health preoccupied with the Global South? Why does mental health in the Global South primarily revolve around the psycho-pharmaceutical, while psychosomatic medicine, which in the German context is a separate discipline divorced from psychiatry, is normatively built on eschewing psycho-pharmaceuticals? Why is mental health in the Global South built on the distinction between superstition (past lives, trance, possession – in short, ‘rituals’ invoking the spirits and the dead) and science (psychiatry, rational diagnosis, asylums, drugs), while in Germany the two are often fused?
Comparable studies
Other qualitative studies on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin | 2017 | Qualitative study | n = 20 |
| LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Patients with anxiety associated with life-threatening diseases | 2014 | Prospective follow-up with qualitative content analysis | n = 10 |
| Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis | 2017 | Qualitative study | n = 13 |
| Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study | 2018 | Qualitative follow-up study using semi-structured interviews and thematic analysis | n = 12 |
| The hidden therapist: evidence for a central role of music in psychedelic therapy Patients undergoing psychedelic therapy with psilocybin for treatment-resistant depression | 2018 | Qualitative study | n = 19 |